T1	Chemical	0 36	Combining Onartuzumab with Erlotinib
T2	Phenotype	46 59	Growth of Non
T3	Disease	46 87	Growth of Non-Small Cell Lung Cancer with
T4	Limited_variation	99 117	EGFR Mutations and
T5	Phenotype	118 138	HGF Overexpression .
R1	decreases	Arg1:T1	Arg2:T2
R2	decreases	Arg1:T1	Arg2:T3
R3	increases	Arg1:T1	Arg2:T4
R4	increases	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	increases	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	increases	Arg1:T3	Arg2:T4
R12	increases	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	decreases	Arg1:T4	Arg2:T2
R15	decreases	Arg1:T4	Arg2:T3
R16	increases	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	decreases	Arg1:T5	Arg2:T2
R19	decreases	Arg1:T5	Arg2:T3
R20	increases	Arg1:T5	Arg2:T4
